🇪🇺 Vaxchora in European Union

EMA authorised Vaxchora on 1 April 2020

Marketing authorisation

EMA — authorised 1 April 2020

  • Application: EMEA/H/C/003876
  • Marketing authorisation holder: Bavarian Nordic A/S
  • Local brand name: Vaxchora
  • Indication: Vaxchora is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years and older. This vaccine should be used in accordance with official recommendations.
  • Status: approved

Read official source →

Vaxchora in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in European Union

Frequently asked questions

Is Vaxchora approved in European Union?

Yes. EMA authorised it on 1 April 2020.

Who is the marketing authorisation holder for Vaxchora in European Union?

Bavarian Nordic A/S holds the EU marketing authorisation.